Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...
Public health experts have been alarmed by Donald Trump picking a vaccine-skeptic to head the US Department of Health and Human Services. Robert F. Kennedy Jr.'s nomination comes as falling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback